SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A trust associated with affiliate Roelof Botha has filed a notice of intent to sell $17.7 million worth of Natera stock, a transaction that is minor relative to the company's large market capitalization.
• Market Impact: Neutral. The sale is unlikely to have a material impact on the stock price due to its small size relative to the company's market value and shares outstanding.

Company Information

Field	Value
Company	Natera, Inc.
Ticker Symbol	NTRA
CIK	0001604821
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Roelof Botha
CIK	0001222287
Title/Position	Not specified
Relationship	Affiliate

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-24 (Approximate Sale Date)
Transaction Code	S (Proposed Sale)
Security Type	Common Stock
Shares Involved	75,000
Price Per Share	~$236.12 (calculated)
Total Value	$17,709,000
Shares Owned After	Not Stated
Ownership Type	Indirect (via BV369 TRUST)

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$17,709,000
% of Market Cap	0.063%
Shares Transacted	75,000
% of Shares Outstanding	0.054%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Natera is a large-cap company with a market capitalization of $28.19 billion. The $17.7 million proposed sale is insignificant in this context.
• Ownership Concentration: The sale represents a very small fraction (0.054%) of the 138 million shares outstanding, having no meaningful impact on ownership structure.
• Transaction Significance: Based on the transaction value being well below 0.1% of both market cap and shares outstanding, its overall significance is low. Such sales by early investors or affiliates are common and often part of pre-planned financial management.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The size of the proposed sale is too small to exert any meaningful pressure on the stock price of a company with a $28.19 billion market capitalization.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transaction will likely be absorbed by the market without a noticeable spike in trading volume.
• Sentiment Indicator: Neutral. The filing is a routine notice of a proposed sale by an affiliate and does not signal a change in the insider's fundamental view of the company.

Additional Context

Transaction Notes

• Filing Type: This Form 144 is a notice of a proposed sale of restricted securities, not a completed transaction. The sale is planned to occur on or around November 24, 2025.
• Special Circumstances: The seller is the BV369 TRUST, with Roelof Botha (a partner at venture capital firm Sequoia Capital) acting as trustee. This suggests the sale is likely related to portfolio management for an early institutional or affiliated investor.